|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Veterinary Medicine / Faculty of Veterinary Medicine >
Peer-reviewed Journal Articles, etc >
Serial measurement of pancreatic lipase immunoreactivity concentration in dogs with immune-mediated disease treated with prednisolone
| Title: | Serial measurement of pancreatic lipase immunoreactivity concentration in dogs with immune-mediated disease treated with prednisolone |
| Authors: | Ohta, H. Browse this author →KAKEN DB | | Morita, T. Browse this author | | Yokoyama, N. Browse this author | | Osuga, T. Browse this author | | Sasaki, N. Browse this author →KAKEN DB | | Morishita, K. Browse this author →KAKEN DB | | Nakamura, K. Browse this author →KAKEN DB | | Takiguchi, M. Browse this author →KAKEN DB |
| Issue Date: | Jun-2017 |
| Publisher: | John Wiley & Sons |
| Journal Title: | Journal of small animal practice |
| Volume: | 58 |
| Issue: | 6 |
| Start Page: | 342 |
| End Page: | 347 |
| Publisher DOI: | 10.1111/jsap.12652 |
| PMID: | 28247954 |
| Abstract: | Objectives: In this pilot study, serum canine pancreatic lipase immunoreactivity was measured repeatedly in dogs with various immune-mediated diseases that were treated with immunosuppressive doses of prednisolone. Methods: Ten client-owned dogs with newly diagnosed immune-mediated disease that had normal canine pancreatic lipase immunoreactivity concentrations (200 mu g/l) were treated with 2 to 2.2 mg/kg prednisolone orally once daily as the initial treatment. Serum samples were obtained from each of the dogs prior to treatment and at 1- to 4-week intervals during immunosuppressive treatment. The highest canine pancreatic lipase immunoreactivity concentration detected during immunosuppressive treatment was defined as the peak canine pancreatic lipase immunoreactivity. Results: Peak canine pancreatic lipase immunoreactivity concentrations were classified as normal in two dogs, questionable (201 to 399 mu g/l) in three dogs, and abnormal (≥400 mu g/l) in five dogs. Peak canine pancreatic lipase immunoreactivity concentrations were significantly higher than baseline canine pancreatic lipase immunoreactivity concentrations but there was no evidence of clinical pancreatitis. Clinical Significance: It remains unclear whether the five of 10 dogs with elevated canine pancreatic lipase immunoreactivity during prednisone treatment had subclinical pancreatitis or whether the abnormal results were a consequence of prednisolone administration. |
| Rights: | This is the peer reviewed version of the following article: H. Ohta, T. Morita, N. Yokoyama, T. Osuga, N. Sasaki, K. Morishita, K. Nakamura, M. Takiguchi, Serial measurement of pancreatic lipase immunoreactivity concentration in dogs with immune-mediated disease treated with prednisolone, Journal of Small Animal Practice, Vol. 58, Issue 6, June 2017, which has been published in final form at https://doi.org/10.1111/jsap.12652. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. |
| Type: | article (author version) |
| URI: | http://hdl.handle.net/2115/70667 |
| Appears in Collections: | 獣医学院・獣医学研究院 (Graduate School of Veterinary Medicine / Faculty of Veterinary Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 大田 寛
|
